Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 3

    1.

    Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade.

    Huang J, Bae JO, Tsai JP, Kadenhe-Chiweshe A, Papa J, Lee A, Zeng S, Kornfeld ZN, Ullner P, Zaghloul N, Ioffe E, Nandor S, Burova E, Holash J, Thurston G, Rudge J, Yancopoulos GD, Yamashiro DJ, Kandel JJ.

    Int J Oncol. 2009 Jan;34(1):79-87.PMID: 19082480 [PubMed - indexed for MEDLINE]Related articles

    2.

    Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation.

    Kadenhe-Chiweshe A, Papa J, McCrudden KW, Frischer J, Bae JO, Huang J, Fisher J, Lefkowitch JH, Feirt N, Rudge J, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ.

    Mol Cancer Res. 2008 Jan;6(1):1-9.PMID: 18234958 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Optical Tomographic and Magnetic Resonance Imaging of Tumor Growth and Regression in Mice treated with VEGF Blockade.

    Masciotti J, Abdoulaev G, Provenzano F, Hur J, Papa J, Bae J, Huang J, Yamashiro D, Kandel J, Hielscher A.

    Conf Proc IEEE Eng Med Biol Soc. 2005;1:205-8.PMID: 17282148 [PubMed - in process]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...